CytoSorb in Patients With Liver Failure

Institutul Clinic Fundeni35 enrolled

Overview

Hemoadsorption has been demonstrated to improve liver functional tests in patients with liver failure. The present study investigates the effects of three consecutive sessions of hemoadsorption, performed in accordance to the local protocol for treating patients with acute liver failure, on liver functional tests, severity scores and 30-days mortality. Paraclinical results and severity scores were obtained before and after the three consecutive sessions.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Liver Dysfunction

Interventions

hemoadsorptionPROCEDURE

three consecutive sessions of hemoadsorption in patients with liver failure

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * patients with acute liver failure or acute on chronic liver failure who require hemoadsorption in accordance with local guidelines Exclusion Criteria: * unsigned informed consent * duration of therapy under 12 hours * death before the three consecutive sessions

Locations (1)

Fundeni Clinical Institute

Bucharest, Romania

Outcomes

Primary Outcomes

30 days mortality

Time frame: 30 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.